Lindynette 30

Ethinylestradiol, the active ingredient in Lindynette 30, is a combined oral contraceptive presented as a 30 µg ethinylestradiol / 0.075 mg gestodene tablet for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age, while gestodene provides the progestogenic component that enhances efficacy and cycle control.

GNH USA supplies Lindynette 30 as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All shipments meet EU quality standards and are supported by comprehensive documentation.

Lindynette 30, a combined oral contraceptive, is indicated for the following clinical situations:

Contraception: Provides reliable prevention of pregnancy when taken as prescribed. Regulation of menstrual cycles: Promotes more predictable bleeding patterns and reduces cycle‑related symptoms. Acne management: Improves hormonal acne in women who also require contraception.

Lindynette 30 may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset, often transient. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Spotting or irregular bleeding: especially during the first months. - Mood changes: irritability or emotional fluctuations. - Weight gain: mild fluid retention.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Stroke: ischemic or hemorrhagic events. - Myocardial infarction: heart attack risk, particularly in high‑risk women. - Severe hypertension: sudden increase in blood pressure. - Liver tumor: benign hepatic adenoma. - Anaphylaxis: rare severe allergic reaction.

Before prescribing Lindynette 30, clinicians should consider several safety measures.

Assess cardiovascular risk: evaluate history of thromboembolic disease before initiating therapy. Avoid in smokers over 35 years: increased risk of serious cardiovascular events. Monitor blood pressure: ensure hypertension is controlled prior to and during use. Review concomitant medications: consider drugs that induce hepatic enzymes and may reduce efficacy. Counsel on missed tablets: advise specific steps to maintain contraceptive protection. Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Lindynette 30 can interact with other medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - CYP3A4 enzyme inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive effectiveness. - Potent anticoagulants (e.g., warfarin): combined use can increase risk of thrombotic events.

Moderate Interactions (Monitor Closely): - Antibiotics such as tetracycline: may slightly decrease absorption of estrogen. - Herbal supplements like St. John’s wort: can lower plasma levels of both hormones. - Antiepileptic drugs (e.g., phenytoin, phenobarbital): may require monitoring of contraceptive efficacy.